ROSEN, LEADING INVESTOR COUNSEL, Encourages Teladoc Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TDOC
June 10, 2024 20:00 ET
|
The Rosen Law Firm PA
NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of Teladoc Health, Inc. (NYSE: TDOC) between November 2, 2022 and...
ROSEN, A LONGSTANDING LAW FIRM, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – MRNS
June 10, 2024 20:00 ET
|
The Rosen Law Firm PA
NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of...
CoreCivic Receives Termination Notice From U.S. Immigration and Customs Enforcement At South Texas Family Residential Center
June 10, 2024 19:12 ET
|
CoreCivic, Inc.
CoreCivic, Inc. received notification today from ICE that the agency intends to terminate an inter-governmental service agreement (IGSA)
ROSEN, LEADING INVESTOR COUNSEL, Encourages Humana Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HUM
June 10, 2024 18:42 ET
|
The Rosen Law Firm PA
NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Humana...
Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 10, 2024 18:35 ET
|
Crinetics Pharmaceuticals, Inc.
SAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted...
True Exposure Investments, Inc. réduit les frais de gestion pour la série F de la Portefeuille de risque exogène TruX et dépose à nouveau le rapport de la direction sur le rendement du fonds et les documents d'aperçu du fonds pour 2023.
June 10, 2024 18:14 ET
|
Inukshuk Capital Management Inc.
TORONTO, 10 juin 2024 (GLOBE NEWSWIRE) -- True Exposure Investments, Inc. (TruX) a annoncé aujourd'hui la réduction des frais de gestion sur la série F du Portefeuille de risque exogène TruX (le...
True Exposure Investments, Inc. lowers management fee for series F of the TruX Exogenous Risk Pool and refiles Management Report of Fund Performance and Fund Facts documents for 2023
June 10, 2024 18:14 ET
|
Inukshuk Capital Management Inc.
True Exposure Investments, Inc. lowers management fee for series F of the TruX Exogenous Risk Pool
ROSEN, SKILLED INVESTOR COUNSEL, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important June 21 Deadline in Securities Class Action – GDRX
June 10, 2024 18:13 ET
|
The Rosen Law Firm PA
NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23,...
Bird to Acquire B.C.-Based Civil Infrastructure Contractor for $135 Million, Expects Resulting 10% Full Year Adj. EPS Accretion
June 10, 2024 17:35 ET
|
Bird Construction Inc
TRANSACTION HIGHLIGHTS Establishes Bird in BC’s high-demand civil infrastructure market and adds significant scale and diversification in the region.Expected to enhance Bird’s Adjusted EBITDA Margins...
GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary Cholangitis
June 10, 2024 17:22 ET
|
GENFIT S.A.
Ipsen’s Iqirvo® (elafibranor) 80 mg tablets receives U.S. FDA accelerated approval as a first-in-class treatment for Primary Biliary Cholangitis (PBC)First-ever drug developed in-house by GENFIT to...